NTRB (Nutriband) Other Current Liabilities: $-0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NTRB Nutriband Inc NTRB
59 GF Score
Price $3.08
GF Value $3.23
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband Other Current Liabilities?

Nutriband NTRB +0.98% 59 Other Current Liabilities is $-0.00 Mil as of Apr. 2026. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.23 (Fairly Valued). The stock has 4 warning signs investors should review.

Nutriband's other current liabilities for the quarter that ended in Apr. 2026 was $-0.00 Mil.

Nutriband's quarterly other current liabilities declined from Oct. 2025 ($0.00 Mil) to Jan. 2026 ($0.00 Mil) and declined from Jan. 2026 ($0.00 Mil) to Apr. 2026 ($-0.00 Mil).

Nutriband's annual other current liabilities increased from Jan. 2024 ($-0.00 Mil) to Jan. 2025 ($0.00 Mil) but then stayed the same from Jan. 2025 ($0.00 Mil) to Jan. 2026 ($0.00 Mil).

Nutriband Other Current Liabilities Related Terms

Nutriband Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Nutriband's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutriband Other Current Liabilities Chart

Nutriband Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 0.00

Nutriband Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 -0.00
NTRB
59GF Score
Nutriband Inc NTRB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutriband Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $-0.00 Mil mean?
Nutriband (NTRB) has a Other Current Liabilities of $-0.00 Mil as of Apr. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nutriband.
Is Nutriband's Other Current Liabilities too high?
Nutriband's current Other Current Liabilities is $-0.00 Mil. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's Other Current Liabilities compare to INMB and GRCE?
Nutriband's Other Current Liabilities of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nutriband. Nutriband's current Other Current Liabilities is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.23, compared to a current price of $3.08 — trading 4.6% below its estimated fair value. The current Other Current Liabilities is $-0.00 Mil. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Nutriband (NTRB), the current Other Current Liabilities is $-0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $3.08 is trading 4.6% below its estimated GF Value™ of $3.23. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • Other Current Liabilities: $-0.00 Mil
  • GF Value™: $3.23 vs. price of $3.08 (4.6% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score

Get the complete analysis for NTRB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.08
Price
$3.23
GF Value